“商保创新药目录横空出世”,为什么这条消息值得周末刷屏?曾经因价格高昂而令普通患者望而却步的百万元CAR-T细胞疗法,如今在2025年国家医保谈判中迎来了历史性转机。10月30日,北京全国人大会议中心,2025年国家医保谈判正式启动。与往年相比,今年的谈判机制出现重大创新 - 在基本医保目录之外,首次正式引入“商业健康保险创新药品目录”。这一制度创新立即在资本市场引发热烈反响。次日,A股和港股...
Source Link“商保创新药目录横空出世”,为什么这条消息值得周末刷屏?曾经因价格高昂而令普通患者望而却步的百万元CAR-T细胞疗法,如今在2025年国家医保谈判中迎来了历史性转机。10月30日,北京全国人大会议中心,2025年国家医保谈判正式启动。与往年相比,今年的谈判机制出现重大创新 - 在基本医保目录之外,首次正式引入“商业健康保险创新药品目录”。这一制度创新立即在资本市场引发热烈反响。次日,A股和港股...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.